1-855-378-42281-855-378-4228
One of the out-patient rehab options for individuals in Clipper Mills battling with opioid dependence and addiction is opioid maintenance therapy. Some facilities and doctors are authorized to administer specific medications to opioid dependent people, many that are opioid-based also and are addictive. With low amounts however, the client doesn't experience being high and also doesn't have severe cravings and is not in opioid withdrawal. Methadone is the first drug administered for this purpose, but there are a few more choices currently to choose from.
Methadone is an opioid and can be taken at an outpatient medical center certified to dispense the med, which is taken on a daily basis as a pill or liquid. The price of the med is about one hundred and fifty dolloars a month. Buprenorphine is also an opioid based med, and is a pill often taken one day on, one day off. But different from Methadone that is only be administered in well-regulated clinics, Buprenorphine can be prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is approximately just under $300 /month for the generic version of the drug. There is also a version of buprenorphine containing the drug naloxone, that is a drug that blocks the effects of opioids. An individual taking this formulation, also known as Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken daily, and is priced about $450 per month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other medications mentioned here it's an opioid blocker and isn't an opioid. There is an option to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents an individual from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 per month.
For All Drug and Alcohol Treatment Programs In Clipper Mills, Click Here.
